Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options

This publication has 15 references indexed in Scilit:

• Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study
  American Heart Journal, 2004
• Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
  Circulation, 2003
• Combination therapy for dyslipidemia: safety and regulatory considerations
  The American Journal of Cardiology, 2002
• ACC/AHA/NHLBI clinical advisory on the use and safety of statins
  Journal of the American College of Cardiology, 2002
• Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
  The American Journal of Cardiology, 2002
• Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
  New England Journal of Medicine, 2001
• Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins
  The American Journal of Medicine, 2001
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998